Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · IEX Real-Time Price · USD
5.04
-0.02 (-0.40%)
At close:
May 31, 2023, 4:00 PM
5.03
-0.01 (-0.20%)
After-hours:
May 31, 2023, 6:39 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.46 | 28.65 | 13.29 | 12.84 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth (YoY) | -63.50% | 115.61% | 3.50% | - | - | - | - | - | - | - |
| Cost of Revenue | 0.34 | 2.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 10.12 | 26.59 | 13.29 | 12.84 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 15.34 | 8.7 | 7.92 | 10.82 | 12.51 | 12.77 | 14 | 8.88 | 4.53 | 1.35 |
| Research & Development | 19.61 | 10.16 | 8.84 | 19.42 | 41.76 | 20.59 | 20.47 | 13.93 | 11.92 | 3.37 |
| Other Operating Expenses | 17.66 | 0 | 2.13 | 2.95 | 1.64 | 0 | 3.01 | 0 | 0 | 0 |
| Operating Expenses | 52.62 | 18.86 | 18.9 | 33.18 | 55.9 | 33.37 | 37.48 | 22.81 | 16.44 | 4.72 |
| Operating Income | -42.51 | 7.73 | -5.61 | -20.34 | -55.9 | -33.37 | -37.48 | -22.81 | -16.44 | -4.72 |
| Interest Expense / Income | 0.34 | 0.23 | 4.79 | 4.86 | 5.47 | 5.78 | 5.51 | 2.67 | 1.61 | 0.16 |
| Other Expense / Income | -0.51 | 16.02 | 2.4 | -0.65 | -4.78 | 4.29 | -26.46 | 29.15 | 6.43 | 0.37 |
| Pretax Income | -42.33 | -8.52 | -12.79 | -24.54 | -56.59 | -43.43 | -16.53 | -54.64 | -24.48 | -5.25 |
| Income Tax | -0.79 | 0.03 | -0.03 | -0.02 | -0.13 | -0.04 | -0.02 | 0.03 | -0.02 | -0.02 |
| Net Income | -41.54 | -8.56 | -12.76 | -24.52 | -56.47 | -43.39 | -16.52 | -54.66 | -24.46 | -5.23 |
| Preferred Dividends | 0 | 54.34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Common | -41.54 | -62.9 | -12.76 | -24.52 | -56.47 | -43.39 | -16.52 | -54.66 | -24.46 | -5.23 |
| Shares Outstanding (Basic) | 34 | 30 | 4 | 2 | 1 | 1 | 1 | 0 | 0 | 0 |
| Shares Outstanding (Diluted) | 34 | 30 | 4 | 2 | 1 | 1 | 1 | 0 | 0 | 0 |
| Shares Change | 15.87% | 647.71% | 114.79% | 65.39% | 22.36% | 0.38% | 98.10% | 209.47% | - | - |
| EPS (Basic) | -1.20 | -2.11 | -3.21 | -13.23 | -50.39 | -47.36 | -18.08 | -118.72 | -164.32 | -35.20 |
| EPS (Diluted) | -1.20 | -2.11 | -3.21 | -13.23 | -50.39 | -47.36 | -18.08 | -118.72 | -164.32 | -35.20 |
| Free Cash Flow Per Share | -0.55 | 0.35 | -0.49 | -12.82 | -48.39 | -36.34 | -33.34 | -44.30 | -98.90 | -29.30 |
| Gross Margin | 96.72% | 92.81% | 100.00% | 100.00% | - | - | - | - | - | - |
| Operating Margin | -406.44% | 26.98% | -42.21% | -158.40% | - | - | - | - | - | - |
| Profit Margin | -397.24% | -219.54% | -96.03% | -191.00% | - | - | - | - | - | - |
| Free Cash Flow Margin | -179.86% | 36.08% | -14.84% | -185.08% | - | - | - | - | - | - |
| EBITDA | -41.05 | -8.04 | -7.74 | -19.38 | -50.8 | -37.32 | -10.85 | -51.88 | -22.8 | -5.02 |
| EBITDA Margin | -392.52% | -28.06% | -58.22% | -150.96% | - | - | - | - | - | - |
| Depreciation & Amortization | 0.94 | 0.26 | 0.27 | 0.3 | 0.32 | 0.34 | 0.18 | 0.08 | 0.08 | 0.07 |
| EBIT | -41.99 | -8.3 | -8.01 | -19.69 | -51.12 | -37.65 | -11.02 | -51.97 | -22.87 | -5.09 |
| EBIT Margin | -401.55% | -28.95% | -60.27% | -153.33% | - | - | - | - | - | - |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).